default author photo

Jan Münch

University of Ulm

SCHOLARLY PAPERS

2

DOWNLOADS

204

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial

Number of pages: 37 Posted: 09 Nov 2024
University of Ulm, Charité - Universitätsmedizin Berlin, University of Besançon - Université de Franche-Comté, Charité - Universitätsmedizin Berlin, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University of Ulm, Stauferklinikum Schwäbisch Gmünd, University of Ulm, University of Ulm, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, University of Ulm, University of Ulm, University of Ulm, University of Ulm, University of Ulm, University of Ulm, Charité - Universitätsmedizin Berlin - Department of Nephrology and Medical Intensive Care, German Red Cross Blood Transfusion Service, University of Ulm, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University of Besançon - Université de Franche-Comté, University Hospital Ulm, Besançon Clinical Investigation Center, University of Besançon - Université de Franche-Comté, German Red Cross Blood Transfusion Service, UK Health Security Agency, University of Oxford, University of Oxford, University of Besançon - Université de Franche-Comté, Erasmus MC, University Medical Center, Aix-Marseille University - Etablissement Français du Sang (EFS) and Ulm University - Ulm University Hospital
Downloads 166 (456,852)
Citation 1

Abstract:

Loading...

convalescent plasma, COVID-19, randomized trial, neutralizing antibody, SARS-CoV-2

2.

Transduction Enhancing Ef-C Peptide Nanofibrils are Endocytosed by Macropinocytosis and Subsequently Degraded

Number of pages: 22 Posted: 20 Sep 2024
University of Ulm, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ulm University, affiliation not provided to SSRN, Ulm University and Ulm University
Downloads 38 (1,236,159)

Abstract:

Loading...

peptide nanofibrils, transduction enhancer, macropinocytosis, lysosomal degradation, retroviral transduction